{'fraction_non_alphanumeric': 0.015978695073235686, 'fraction_numerical': 0.009320905459387484, 'mean_word_length': 5.836363636363636, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of Supplementary Oral Estrogen on Long-Acting Injectable Progestogen Contraception

Continuous daily oral administration of 1 mg of stilbestrol during the 3 months following the first injection of the contraceptive, depo-medroxy-progesterone acetate, 150 mg, failed to diminish the incidence of uterine bleeding when compared with controls. Such supplemental estrogen did not significantly alter the appearance of endometrial biopsies or karyopyknotic indices. Cyclic administration of supplemental oral estrogen for 3 weeks of a 4-week period caused regular withdrawal uterine bleeding. It was concluded that there is little advantage in giving supplemental oral estrogen to patients using long-acting injectable progestogen for contraception.